Anteris Technologies Ltd
Anteris Technologies Ltd
Your view on AVR.AX
Overview
What the company does, where it operates, and who runs it.
About Anteris Technologies Ltd
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Wayne Geoffrey Paterson
- Headquarters
- Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, QLD, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Wayne Geoffrey Paterson
- Headquarters
- Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, QLD, AU
Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology.
The company is also actively involved in advancing DurAVR™, an innovative 3D single-component aortic valve specifically designed for treating aortic stenosis. Additionally, Anteris allocates resources to the research and development of regenerative medicines.
Founded in 1999, the enterprise was formerly known as Admedus Limited until it rebranded to Anteris Technologies Ltd in May 2020. Its primary operations are conducted from its base in Toowong, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Anteris Technologies Ltd. Starting points for Anteris Technologies Ltd: EPS -AUD 0.81, beta 0.73 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Anteris Technologies Ltd. Anteris Technologies Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Anteris Technologies Ltd. Trailing twelve-month EPS for Anteris Technologies Ltd stands at -AUD 0.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrMar 2027 | Next QtrSep 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | −$0.35 | −$0.30 | −$1.61 | −$1.72 |
| Low estimate | −$0.35 | −$0.30 | −$1.84 | −$1.78 |
| High estimate | −$0.35 | −$0.30 | −$1.37 | −$1.66 |
| No. of analysts | 1 | 1 | 2 | 2 |
| Year-ago EPS | −$0.381 | −$2.031 | −$2.611 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrMar 2027 | Next QtrSep 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $291886.00 | $1.17M | $5.20M | $3.79M |
| Low estimate | $291886.00 | $1.17M | $4.59M | $3.35M |
| High estimate | $291886.00 | $1.17M | $5.77M | $4.21M |
| No. of analysts | 1 | 1 | 3 | 4 |
| Year-ago revenue | $404901.00 | $1.29M | $1.91M | — |
| Growth | −27.9% | −9.8% | +171.7% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Anteris Technologies Ltd. Anteris Technologies Ltd has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ARX.AXAroa Biosurgery Limited | Healthcare | Medical - Devices | — | ||
| PNV.AXPolyNovo Limited | Healthcare | Medical - Devices | — | ||
| TTX.AXTetratherix Ltd. | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CMP.AXCompumedics Limited | Healthcare | ASX | — | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| CNVIFConavi Medical Corp. | Healthcare | OTC | $20.7M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Anteris Technologies Ltd. Coverage tracks Anteris Technologies Ltd within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Anteris Technologies Ltd.